medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2012, Number 2

<< Back Next >>

Arch Neurocien 2012; 17 (2)

Personalized medicine: toward a new model in medical practice

Medrano-Hernández AM

Language: Spanish
References: 18
Page: 129-131
PDF size: 52.05 Kb.


ABSTRACT

The evolution of medicine is a constant and today we are living the transition to the personalized medicine. There is no a unique definition but all of them are based on the individualization of the treatment to a specific patient. This individualization is based on the genetic sequence that each individual has. The principal characteristics of this model is the personalization, prediction, prevention and the patient participation, which benefits the patient by early detection of disease, as well as the possibility to choose the correct treatment with the correct dosification, increase the therapeutic adherence, prevent adverse effects, increase the life quality and reduce the total cost of health attention.


REFERENCES

  1. Snyderman R. Personalized health care: from theory to practice Review. Biotechnol J 2012;7:1-7.

  2. Snyderman R, Sanders WR, Prospective medicine: The next health care transformation. Acad Med 2003; 78:1079-84.

  3. Williams RS, Willard HF, Snyderman R. Personalized health planning. Science 2003; 300:549.

  4. Weston AD, Hood L, Systems biology, proteomics, and the future of health care: Toward predictive, preventative, and personalized medicine. J Proteome Res 2004; 3: 179-96.

  5. Snyderman R, Langheier J. Prospective health care: the second transformation of medicine. Genome Biol 2006;7:104.

  6. Bousquet J, Anto JM, Sterk PJ, Adcock IM. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 2011;3:43.

  7. Personalized Medicine Coalition. 2010. < http://www.persona lizedmedicinecoalition.org/>

  8. Personalized Medicine Coalition. Personalized Medicine: An Introduction.< http://www.personalizedmedicinecoalition. org/sites/default/files/personalmed_backgrounder.pdf>

  9. Brown NJ. Patient-oriented research in the era of personalized medicine. Clin Transl Sci 2012;5(2):119-20

  10. Bottinger EP. Foundations, promises and uncertainties of personalized medicine. Mt Sinai J Med 2007; 74:15-21.

  11. Ziv E, Burchard EG. Human population structure and genetic association studies. Pharmacogenomics 2003;4(4):431-41.

  12. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003; 348(12):1170-5.

  13. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004;306:640-3.

  14. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome 2009;1:2.

  15. Personalized medicine coalition. The case for personalized medicine. Personalized medicine coalition 3a edición.

  16. Snyderman R, Dinan MA. Improving health by taking it personally. JAMA 2010; 303:363-4.

  17. Somberg J. Is there an imperative for generic profiling to hasten the age of personalized medicine. Am J Therapeutics 2012; 19:163.

  18. Kelly C, Pritchard KI. Personalized medicine: what exactly is it and can we truly measure it?. J Clin Oncol 2012;30:1-2.




2020     |     www.medigraphic.com